INSM

Insmed Incorporated (INSM)

Last Price$83.6(0.3%)
Market Cap$14.5B
DCF value
N/A
Overvalued (DCF value)
(100.0%)
Discount Rate
9.5%
Long-Term Growth Rate
3.0%
Stock quality
6/10
Good

INSM DCF Model

Free Cash Flow to Firm Model
NOPAT Model
Free Cash Flow to Equity Model
Net Income Model
Millions
Billions
Dec'19 ActualDec'20 ActualDec'21 ActualDec'22 ActualDec'23 ActualDec'24 EstimateDec'25 EstimateDec'26 EstimateDec'27 EstimateDec'28 EstimateDec'29 EstimateDec'30 EstimateDec'31 EstimateDec'32 EstimateDec'33 EstimateDec'34 Terminal
% growth
136.5
1,287.6%
164.4
20.5%
188.5
14.6%
245.4
30.2%
305.2
24.4%
357.9
17.3%
509.5
42.4%
1,014.7
99.1%
1,857.1
83.0%
2,763.0
48.8%
3,900.2
41.2%
5,207.6
33.5%
6,556.1
25.9%
7,753.3
18.3%
8,577.6
10.6%
8,834.9
3.0%
(235.2)
(172.4%)
(265.2)
(161.3%)
(367.8)
(195.1%)
(478.1)
(194.9%)
(709.6)
(232.5%)
(357.9)
(100.0%)
(509.5)
(100.0%)
(1,014.7)
(100.0%)
(1,857.1)
(100.0%)
(2,763.0)
(100.0%)
(3,900.2)
(100.0%)
(5,207.6)
(100.0%)
(6,556.1)
(100.0%)
(7,753.3)
(100.0%)
(8,577.6)
(100.0%)
(8,834.9)
(100.0%)
NOPAT
% effective tax rate
(236.0)
(172.9%)
(266.5)
(162.1%)
(366.3)
(194.4%)
(479.5)
(195.4%)
(712.1)
(233.3%)
(359.1)
(100.3%)
(511.3)
(100.3%)
(1,018.1)
(100.3%)
(1,863.4)
(100.3%)
(2,772.5)
(100.3%)
(3,913.5)
(100.3%)
(5,225.5)
(100.3%)
(6,578.5)
(100.3%)
(7,779.8)
(100.3%)
(8,606.9)
(100.3%)
(8,865.1)
(100.3%)
% of revenue
10.2
7.5%
20.1
12.2%
27.8
14.8%
24.3
9.9%
10.6
3.5%
33.6
9.4%
47.8
9.4%
95.2
9.4%
174.2
9.4%
259.1
9.4%
365.8
9.4%
488.4
9.4%
614.8
9.4%
727.1
9.4%
804.4
9.4%
828.5
9.4%
% of revenue
(42.3)
(31.0%)
(6.8)
(4.1%)
(7.3)
(3.9%)
(9.9)
(4.0%)
(13.3)
(4.4%)
(14.6)
(4.1%)
(20.8)
(4.1%)
(41.4)
(4.1%)
(75.8)
(4.1%)
(112.8)
(4.1%)
(159.2)
(4.1%)
(212.6)
(4.1%)
(267.6)
(4.1%)
(316.5)
(4.1%)
(350.2)
(4.1%)
(360.7)
(4.1%)
(63.0)
(46.1%)
(3.0)
(1.8%)
(58.6)
(31.1%)
6.6
2.7%
(39.2)
(12.8%)
(49.2)
(13.8%)
(70.1)
(13.8%)
(139.5)
(13.8%)
(255.4)
(13.8%)
(379.9)
(13.8%)
(536.3)
(13.8%)
(716.1)
(13.8%)
(901.5)
(13.8%)
(1,066.2)
(13.8%)
(1,179.5)
(13.8%)
(1,214.9)
(13.8%)
Free Cash Flow to Firm (FCFF)
% of revenue
(331.0)
(242.6%)
(256.2)
(155.8%)
(404.3)
(214.5%)
(458.5)
(186.9%)
(754.0)
(247.0%)
(389.4)
(108.8%)
(554.3)
(108.8%)
(1,103.9)
(108.8%)
(2,020.4)
(108.8%)
(3,006.1)
(108.8%)
(4,243.3)
(108.8%)
(5,665.8)
(108.8%)
(7,132.8)
(108.8%)
(8,435.4)
(108.8%)
(9,332.2)
(108.8%)
(9,612.2)
(108.8%)
% of FCFF used in calculation
100.0%
86.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Discount period
0.50
1.50
2.50
3.50
4.50
5.50
6.50
7.50
8.50
Discount factor
0.96
0.87
0.80
0.73
0.67
0.61
0.56
0.51
0.46
Discounted FCFF (DFCFF)

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

INSM DCF Value

DCF Value Calculation

as of Feb 20, 2025
Sum of DFCFF
% share of EV
N/A
30.0%
Terminal Value (TV)
N/A
Discounted TV
% share of EV
N/A
70.0%
Total Debt
1,204.0M
Shares outstanding
173.7M
FX rate
N/A
100% overvalued

Equity Value Bridge

Sum ofDFCFDiscountedterminalvalueEnterprisevalueCash &Short-TermInvestmentsTotal debtEquityvalue0.00.00.0780.4M1,204.0M423.5M

INSM DCF Financials

Revenue
$305.2M -> $8,577.6M 39.6% CAGR
Operating Income
($709.6M) -> ($8,577.6M) 28.3% CAGR
FCFF
($754.0M) -> ($9,332.2M) 28.6% CAGR
($5,000.0M)$0.0$5,000.0MDec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29Dec'30Dec'31Dec'32Dec'33
Revenue
Operating Income
FCFF

INSM DCF sensitivity

DCF value
Long-term Terminal growth rate
2.0%
2.5%
3.0%
3.5%
4.0%
WACC
8.0%
$0.0
$0.0
$0.0
$0.0
$0.0
8.5%
$0.0
$0.0
$0.0
$0.0
$0.0
9.5%
$0.0
$0.0
$0.0
$0.0
$0.0
9.5%
$0.0
$0.0
$0.0
$0.0
$0.0
10.0%
$0.0
$0.0
$0.0
$0.0
$0.0
DCF value, undervalued / overvalued
Long-term Terminal growth rate
2.0%
2.5%
3.0%
3.5%
4.0%
WACC
8.0%
(100.0%)
(100.0%)
(100.0%)
(100.0%)
(100.0%)
8.5%
(100.0%)
(100.0%)
(100.0%)
(100.0%)
(100.0%)
9.5%
(100.0%)
(100.0%)
(100.0%)
(100.0%)
(100.0%)
9.5%
(100.0%)
(100.0%)
(100.0%)
(100.0%)
(100.0%)
10.0%
(100.0%)
(100.0%)
(100.0%)
(100.0%)
(100.0%)

Explore more intrinsic value tools hub for INSM

FAQ

What is Insmed Incorporated DCF (discounted cash flow) valuation?

As of Feb 20, 2025, Insmed Incorporated's Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by (100.0%) compared to its current price of around $83.6, using a WACC of 9.5% and growth rates of 3.0%.

What is Insmed Incorporated WACC?

As of Feb 20, 2025, Insmed Incorporated's Weighted Average Cost of Capital (WACC) is approximately 9.5%.

What is Insmed Incorporated Enterprise Value?

As of Feb 20, 2025, Insmed Incorporated's Enterprise Value (EV) is approximately $0.0. This value reflects the company's total market capitalization plus debt, minus cash and cash equivalents, providing a comprehensive measure of its overall value in the market.